Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated for the treatment of type 2 diabetes and long-term weight management. It works by mimicking the intestinal hormone GLP-1 through mechanisms that include: stimulating insulin secretion to lower blood glucose; delaying gastric emptying, increasing satiety, and suppressing appetite to aid weight loss. Semaglutide is typically administered as a once-weekly subcutaneous injection.
Primary Mechanisms of Action:
• Hypoglycemic Effect: When blood glucose levels rise, semaglutide stimulates insulin secretion while inhibiting glucagon release, thereby lowering blood sugar.
• Weight Management Effects: Semaglutide delays gastric emptying, increases satiety, and reduces food intake, thereby achieving weight loss.
Uses and Advantages:
• Treatment of Type 2 Diabetes: Semaglutide effectively controls blood glucose levels in patients with type 2 diabetes.
• Significant Weight Loss Effects: Semaglutide demonstrates highly effective weight loss outcomes and is listed in numerous guidelines as a medication with exceptional weight reduction efficacy.
• Low risk of hypoglycemia: Due to its glucose-dependent mechanism, it avoids excessive insulin stimulation during low blood sugar, reducing the likelihood of severe hypoglycemia with monotherapy.
• Convenient administration: Most formulations require only weekly injections, offering greater convenience than daily injections.
Product Display
Analysis Report
Customer Feedback
Packaging And Transportation
